𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infectious complications of tumor necrosis factor-α antagonists

✍ Scribed by Mohanad Bakleh; Imad Tleyjeh; Eric L. Matteson; Douglas R. Osmon; Elie F. Berbari


Book ID
110877366
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
106 KB
Volume
44
Category
Article
ISSN
0011-9059

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Life-threatening histoplasmosis complica
✍ Jong-Hoon Lee; Nancy R. Slifman; Sharon K. Gershon; Evelyne T. Edwards; William 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## Objective Two tumor necrosis factor α (TNFα) antagonists were recently licensed in the US. Infliximab was licensed in 1998 for the treatment of Crohn's disease (CD), and since 1999, it has been licensed in combination with methotrexate for treatment of rheumatoid arthritis (RA). Eta